Drawing for SENSIGRIP

USPTO serial 79440729

SENSIGRIP

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
—
Examiner
PURATH, ANICKA S
Law office
TMEG LAW OFFICE 101

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with SENSIGRIP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nels T. Lippert

Nels T. Lippert Tarter Krinsky & Drogin LLP1350 Broadway, 11th Fl.New York, NY 10018United States

Goods and services

ClassDescriptionStatusFirst use
005Swabs for medical purposes, namely, swabs for the collection, preservation and transport of viruses, bacteria and other microorganisms, for medical purposes; flocked and absorbent swabs for medical purposes, namely, flocked and absorbent swabs for the collection, preservation and transport of viruses, bacteria and microorganisms, for medical purposes; kits consisting of swabs for medical purposes impregnated with culture media for use in the preservation and transport of viruses, bacteria and microorganisms, for medical purposes; swabs for medical use, namely, swabs for the collection, preservation, and transport of viruses, bacteria and microorganisms, for medical use; flocked swabs for medical use, namely, flocked swabs for the collection, preservation and transport of viruses, bacteria and microorganisms, for medical use; kits comprising swabs for medical use impregnated with culture media for use in the preservation and transport of viruses, bacteria and microorganisms, for medical use; kits comprising flocked swabs for medical use impregnated with culture media for use in the preservation and transport of viruses, bacteria and microorganisms, for medical useACTIVE—
009Laboratory disposable devices for collecting, preserving and transporting biological and chemical samples and substances, not for medical purposes, namely, laboratory swabs; laboratory swabs for the collection, preservation and transport of viruses, bacteria, and microorganisms, not for medical use; flocked laboratory swabs for the collection, preservation and transport of viruses, bacteria, and microorganisms, not for medical use; laboratory test tubes containing preservation and transport media for viruses, bacteria and microorganisms, not for medical use; laboratory containers in the nature of test tubes and kits comprised of scientific laboratory research specimen collection devices in the nature of swabs for the collection of cervical specimen, all the foregoing for use in the transport and preservation of biological, chemical and diagnostic testing samples, not for medical use; laboratory kits comprising laboratory swabs and test tubes containing preservation and transport media for viruses, bacteria and microorganisms, not for medical use; laboratory kits comprising flocked laboratory swabs and test tubes containing preservation and transport media for viruses, bacteria and microorganisms, not for medical useACTIVE—
010Medical specimen collection devices in the nature of test tubes containing preservation and transport media for the collection of cervical specimen for use in testing for viruses, bacteria and microorganisms, for medical use; containers and kits for the transport and preservation of biological, chemical and diagnostic samples, for medical use, namely, containers in the nature of medical specimen cups and kits comprising medical specimen collection devices in the nature of swabs for the collection of cervical specimen; kits comprising medical specimen collection devices in the nature of test tubes containing preservation and transport media for the collection of cervical specimen for use in testing for viruses, bacteria and microorganisms, for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 8, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 8, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 8, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 10, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 10, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 10, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2026RFNTREFUSAL PROCESSED BY IB—
Feb 12, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 12, 2026RFRRREFUSAL PROCESSED BY MPU—
Jan 15, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 14, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 7, 2026DOCKASSIGNED TO EXAMINER—
Jan 6, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 6, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 1, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance